Back to Search Start Over

Is the Combination of a GLP-1 Agonist and a SGLT2 Inhibitor Safe?

Source :
Internal Medicine Alert. 10/30/2023, Vol. 45 Issue 20, p1-8. 8p.
Publication Year :
2023

Abstract

The article focuses on the study that investigated the combination of SGLT2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes and its impact on cardiovascular events.

Details

Language :
English
ISSN :
0195315X
Volume :
45
Issue :
20
Database :
Academic Search Index
Journal :
Internal Medicine Alert
Publication Type :
Periodical
Accession number :
173241320